Insulin Resistance Syndrome: Difference between revisions

Latest revision as of 03:24, 17 November 2007

Redirect to:

Revision as of 18:20, 26 January 2007 (view source) imported>Nancy Sculerati MD No edit summary ← Older edit		Latest revision as of 03:24, 17 November 2007 (view source) imported>Pierre-Alain Gouanvic (Redirecting to Metabolic syndrome)
(6 intermediate revisions by 6 users not shown)
Line 1:		Line 1:
	~~The '''insulin resistance syndrome''' is a "constellation of findings, including [[central obesity]], [[glucose intolerance]], [[dyslipidemia]], and [[hypertension]], that promotes the development of~~ [[type 2 diabetes mellitus]], [[cardiovascular disease]], [[Cancer\|cancer]], polycystic ovarian disease (PCOS), and nonalcoholic fatty liver disease".(reference for quote: Sudha B. Biddinger & C. Ronald Kahn : FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes.Annual Review of Physiology Vol. 68: 123-158 (Volume publication date January 2006) (doi:10.1146/annurev.physiol.68.040104.124723)). As [[Obesity\|obesity]] has reached epidemic proportions in many countries of the developed world, a pattern of these findings has become recognized. Also called the metabolic syndrome~~, the dysmetabolic syndrome, or syndrome, this association of [[Physiology\|physiologic findings]] is the focus of current research in [[medicine~~]].		#REDIRECT [[Metabolic syndrome]]